Dr. Hannestad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
34 Park Street
New Haven, CT 06519Phone+1 203-932-5711
Education & Training
- Yale-New Haven Medical CenterResidency, Psychiatry, 2005 - 2006
- Duke University HospitalResidency, Internal Medicine/Psychiatry, 2003 - 2004
- Duke University HospitalInternship, Transitional Year, 2002 - 2003
- OtherClass of 1996
Certifications & Licensure
- MD State Medical License 2024 - 2026
- CA State Medical License 2017 - 2023
- CT State Medical License 2005 - 2017
Publications & Presentations
PubMed
- 7 citationsCCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain.Sanket V Rege, Arnaud Teichert, Juliet Masumi, Onkar S Dhande, Reema Harish
Communications Biology. 2023-03-18 - 6 citationsDrug characteristics derived from kinetic modeling: combinedC-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A.Mika Naganawa, Jean-Dominique Gallezot, Sjoerd J Finnema, Ralph Paul Maguire, Joël Mercier
EJNMMI Research. 2022-11-08 - 9 citationsSafety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.Jonas Hannestad, Tiffanie Duclos, Whitney Chao, Katie Koborsi, Vicki Klutzaritz
Journal of Alzheimer's Disease. 2021-01-01
Press Mentions
- Tranquis Therapeutics Announces Initiation of Phase 1 Study of TQS-168December 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: